NBME 20 Discontinue the new drug in affected patients and file MedWatch reports on the FDA's Web site (NBME Answers)

need help with your account or subscription? click here to email us (or see the contact page)

search for anything ⋅ score predictor (“predict me!”)

NBME 20 Answers

nbme20/Block 2/Question#46 (reveal difficulty score)
A physician prescribes a newly marketed drug ...
Discontinue the new drug in affected patients and file MedWatch reports on the FDA's Web site 🔍 / 📺 / 🌳 / 📖
tags: pharm

+16 upvote downvote
submitted by ∗strugglebus(189)

get full access to all content ⋅ pick a username

I chose this solely because it was so damn specific

get full access to all content ⋅ pick a username

sympathetikey Same. Learn something new every day: See more: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program +5

karljeon I didn't choose it because it was so damn specific. :( +48

lovebug Could anyone explain for B) for me? because I choose B).:( +2

j44n B.) is wrong because its never been shown to show adverse effects "any offcial data linking the drug" and the fact that it's "newly marketed" +

j44n and because its in 5/45 patients roughly 10% of the population, that might not seem like much but most of the diseases we freak out over are in 1-2% of the population, to put that into perspective if we gave this drug to every person in the US (every big pharma wet dream) with a population of 300 million... 30 million people would have this adverse event... hope that helps +

+10 upvote downvote
submitted by ∗hello_planet(43)

get full access to all content ⋅ pick a username

The question stem describes that the drug is "newly marketed", so it's likely in Phase IV drug trials.

From FA 2019 pg. 256, Phase IV = "Postmarketing surveillance of patients after treatment is approved." Phase IV is for detecting rare side effects that weren't picked up during the smaller clinical trials or long-term effects. Phase IV determines if the drug can stay on the market.

The drug is approved and is appropriate to use in patients without side effects, but the drug is still being monitored by the FDA so any new, previously unreported side effects need to be filed with the FDA.

get full access to all content ⋅ pick a username

-2 upvote downvote
submitted by ∗rockodude(39)

get full access to all content ⋅ pick a username

always do no harm ppl, comes up again and again and again

get full access to all content ⋅ pick a username

Must-See Comments from nbme20

amorah on Cytomegalovirus infection
masonkingcobra on Contact with parakeets
hayayah on Capillary hydrostatic: increased; ...
hayayah on X chromosome-linked isoenzymes
medbitch94 on Mannose 6-phosphate
hello on Capillary hydrostatic: increased; ...
hayayah on Osteoblasts
imgdoc on Hypophosphatemia
hayayah on Missense
celeste on 50%
justgettinby on Omeprazole
andrewk1 on Cold, dry air
yotsubato on Jugular venous pressure of 12 mm Hg
strugglebus on Drug effect